Best Medical Stocks To Watch Today – February 06th

Eli Lilly and Company, UnitedHealth Group, and Tempus AI are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of companies within the healthcare industry that are involved in the manufacturing, distribution, and development of medical products, devices, and technologies used for diagnosing and treating medical conditions. These stocks can include pharmaceutical companies, medical equipment manufacturers, and healthcare service providers. Investors may choose to invest in medical stocks for potential growth and profit opportunities within the healthcare sector. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY stock traded up $29.72 on Thursday, reaching $871.90. 4,240,330 shares of the stock were exchanged, compared to its average volume of 3,870,691. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.27 and a quick ratio of 0.97. Eli Lilly and Company has a one year low of $707.02 and a one year high of $972.53. The stock has a market cap of $827.72 billion, a PE ratio of 94.57, a P/E/G ratio of 1.72 and a beta of 0.42. The stock has a 50 day moving average price of $786.57 and a 200 day moving average price of $843.28.

Read Our Latest Research Report on LLY

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of NYSE UNH traded down $12.20 during mid-day trading on Thursday, hitting $527.61. The company’s stock had a trading volume of 1,701,130 shares, compared to its average volume of 4,352,653. The company’s fifty day simple moving average is $532.43 and its 200-day simple moving average is $564.77. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The stock has a market cap of $485.55 billion, a price-to-earnings ratio of 34.04, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

Read Our Latest Research Report on UNH

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Shares of Tempus AI stock traded down $3.18 on Thursday, hitting $66.00. 13,467,735 shares of the company’s stock traded hands, compared to its average volume of 11,388,136. Tempus AI has a one year low of $22.89 and a one year high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The firm’s 50-day moving average price is $44.32 and its two-hundred day moving average price is $48.73.

Read Our Latest Research Report on TEM

Read More